China Medical System Holdings Limited (CMS group)

China Medical System Holdings Limited 

China Medical System Holdings Limited (CMS) is a specialized pharmaceutical enterprise with a focus on sales and marketing in China. It was established in 1995, and listed on the Main board of the Hong Kong Stock Exchange on Sep 28, 2010. 

CMS group is committed to offering competitive products and services to meet China's medical needs. It has established diversified introduction strategies and multi-level introduction mechanisms for new products, ensuring the constant supply of innovative and quality products to the market at any stage. CMS focuses on the research of innovative patented drugs and has owned multiple patented drug portfolios, which will have a major significance on human health after being launched to the market.

CMS has a strong and professional marketing network, as well as a promotion platform covering the whole Chinese market. Its professional management team has more than 20 years of experience in the marketing and promotion of drugs. The promotion network has covered all provinces, cities, and most prefecture-level cities in China. CMS has pharmaceutical manufacturing sites in Shenzhen, Hunan province, and Hebei province, producing domestic chemicals, small dose injections, and proprietary Chinese medicine, as well as extracting bulk drugs. CMS has also established an efficient operation and management system, using a self-developed ERP system to ensure it being one of the most efficient companies in the industry.

Relying on high-quality products, the professional promotion network, and the efficient management system, CMS has achieved sustainable and rapid growth with a turnover compound annual growth rate of 30.4 percent, as well as a net profit of 35.8 percent.

Address: 6F-8F, Block B, Majialong Innovation Building, 198 Daxin Road, Nanshan District, Shenzhen, Guangdong Province